Abstract
The Virogen CMV Antibody Test is a simple and rapid latex agglutination assay for the detection of cytomegalovirus antibody in human serum and plasma. Evaluation of this assay with respect to enzyme immunoassay yielded a sensitivity of 98% with a specificity of 100%. In comparison to CMVScan, the Virogen CMV Antibody Test had a sensitivity of 98.4% and a specificity of 100%.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adler S. P., McVoy M., Biro V. G., Britt W. J., Hider P., Marshall D. Detection of cytomegalovirus antibody with latex agglutination. J Clin Microbiol. 1985 Jul;22(1):68–70. doi: 10.1128/jcm.22.1.68-70.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beckwith D. G., Halstead D. C., Alpaugh K., Schweder A., Blount-Fronefield D. A., Toth K. Comparison of a latex agglutination test with five other methods for determining the presence of antibody against cytomegalovirus. J Clin Microbiol. 1985 Mar;21(3):328–331. doi: 10.1128/jcm.21.3.328-331.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bowden R. A., Sayers M., Flournoy N., Newton B., Banaji M., Thomas E. D., Meyers J. D. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med. 1986 Apr 17;314(16):1006–1010. doi: 10.1056/NEJM198604173141602. [DOI] [PubMed] [Google Scholar]
- Bowden R. A., Sayers M., Gleaves C. A., Banaji M., Newton B., Meyers J. D. Cytomegalovirus-seronegative blood components for the prevention of primary cytomegalovirus infection after marrow transplantation. Considerations for blood banks. Transfusion. 1987 Nov-Dec;27(6):478–481. doi: 10.1046/j.1537-2995.1987.27688071699.x. [DOI] [PubMed] [Google Scholar]
- Drew W. L. Cytomegalovirus infection in patients with AIDS. J Infect Dis. 1988 Aug;158(2):449–456. doi: 10.1093/infdis/158.2.449. [DOI] [PubMed] [Google Scholar]
- Leland D. S., Barth K. A., Cunningham E. B., Jansen J., Tricot G. J., French M. L. Evaluation of four methods for cytomegalovirus antibody detection for use by a bone marrow transplantation service. J Clin Microbiol. 1989 Jan;27(1):176–178. doi: 10.1128/jcm.27.1.176-178.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meyers J. D., Flournoy N., Thomas E. D. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis. 1986 Mar;153(3):478–488. doi: 10.1093/infdis/153.3.478. [DOI] [PubMed] [Google Scholar]
- Peterson P. K., Balfour H. H., Jr, Marker S. C., Fryd D. S., Howard R. J., Simmons R. L. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) 1980 Jul;59(4):283–300. [PubMed] [Google Scholar]
- Stagno S., Pass R. F., Dworsky M. E., Henderson R. E., Moore E. G., Walton P. D., Alford C. A. Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N Engl J Med. 1982 Apr 22;306(16):945–949. doi: 10.1056/NEJM198204223061601. [DOI] [PubMed] [Google Scholar]